SCHEMBL6178127

SCHEMBL6178127

CCCCCCO[C](C)OCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.56
TSHR P16473 3/20 0.56
CA12 O43570 3/20 0.54
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
CA9 Q16790 3/20 0.54
EPHX1 P07099 1/20 0.52
ALDH1A1 P00352 2/20 0.50
CES2 O00748 1/20 0.48
HCAR2 Q8TDS4 1/20 0.47
RAD52 P43351 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.46
THRB P10828 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 1/20 0.46
FAAH O00519 1/20 0.45
LMNA P02545 1/20 0.45
ACHE P22303 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11128417 0.97 ALDH1A1 (0.54) NAAATSHRCA12CA1CA2
SCHEMBL6179376 0.97 CA12 (0.54) NAAATSHRCA12CA1CA2
SCHEMBL1527699 0.88 ALDH1A1 (0.62) NAAATSHRCA12CA1CA2
SCHEMBL4517662 0.83 NAAA (0.56) NAAATSHRCA12CA1CA2
SCHEMBL10936195 0.83 NAAA (0.56) NAAATSHRCA12CA1CA2
SCHEMBL11493858 0.83 NAAA (0.56) NAAATSHRCA12CA1CA2
SCHEMBL5226979 0.83 NAAA (0.56) NAAATSHRCA12CA1CA2
SCHEMBL27514704 0.81 NAAA (0.54) NAAATSHRCA12CA1CA2
SCHEMBL27496068 0.81 NAAA (0.54) NAAATSHRCA12CA1CA2
SCHEMBL4071857 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed